Literature DB >> 2039509

Cloning and partial nucleotide sequence of human glutamic acid decarboxylase cDNA from brain and pancreatic islets.

D S Cram1, L D Barnett, J L Joseph, L C Harrison.   

Abstract

We report partial nucleotide sequences of the human enzyme glutamic acid decarboxylase (GAD) from brain and pancreatic islets which encode the middle 180 amino acids of GAD. The brain and islet GAD sequences display a high degree of sequence homology with the equivalent region of other mammalian brain GAD cDNAs. Alignment of the brain and islet GAD sequences showed that there were 45 nucleotide differences which, at the translational level, would result in seven amino acid substitutions. These results which suggest that different isomeric forms of human GAD exist in brain and pancreas may be relevant to the pathogenesis of stiff man syndrome (SMS) and insulin-dependent diabetes mellitus (IDDM), respectively, two distinct but associated clinical disorders in which GAD is the target of autoantibodies.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2039509     DOI: 10.1016/0006-291x(91)90418-7

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  11 in total

1.  Islet-reactive T cells are a marker of preclinical insulin-dependent diabetes.

Authors:  L C Harrison; S X Chu; H J DeAizpurua; M Graham; M C Honeyman; P G Colman
Journal:  J Clin Invest       Date:  1992-04       Impact factor: 14.808

2.  New nucleotide sequence data on the EMBL File Server.

Authors: 
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

3.  Cloning and characterization of myr 6, an unconventional myosin of the dilute/myosin-V family.

Authors:  L P Zhao; J S Koslovsky; J Reinhard; M Bähler; A E Witt; D W Provance; J A Mercer
Journal:  Proc Natl Acad Sci U S A       Date:  1996-10-01       Impact factor: 11.205

4.  A deletion polymorphism in the human alpha-2-macroglobulin (A2M) gene.

Authors:  G Matthijs; P Marynen
Journal:  Nucleic Acids Res       Date:  1991-09-25       Impact factor: 16.971

5.  Glutamic acid decarboxylase (GAD) autoantibodies are additional predictive markers of type 1 (insulin-dependent) diabetes mellitus in high risk individuals.

Authors:  C H Thivolet; M Tappaz; A Durand; J Petersen; A Stefanutti; P Chatelain; B Vialettes; W Scherbaum; J Orgiazzi
Journal:  Diabetologia       Date:  1992-06       Impact factor: 10.122

6.  Two human glutamate decarboxylases, 65-kDa GAD and 67-kDa GAD, are each encoded by a single gene.

Authors:  D F Bu; M G Erlander; B C Hitz; N J Tillakaratne; D L Kaufman; C B Wagner-McPherson; G A Evans; A J Tobin
Journal:  Proc Natl Acad Sci U S A       Date:  1992-03-15       Impact factor: 11.205

7.  Cloning, characterization, and autoimmune recognition of rat islet glutamic acid decarboxylase in insulin-dependent diabetes mellitus.

Authors:  B K Michelsen; J S Petersen; E Boel; A Møldrup; T Dyrberg; O D Madsen
Journal:  Proc Natl Acad Sci U S A       Date:  1991-10-01       Impact factor: 11.205

8.  A convulsant, 3-mercaptopropionic acid, decreases the level of GABA and GAD in rat pancreatic islets and brain.

Authors:  J Katoh; H Taniguchi; M Ogura; M Kasuga; Y Okada
Journal:  Experientia       Date:  1995-03-15

9.  Glutamic acid decarboxylase autoantibodies in preclinical insulin-dependent diabetes.

Authors:  H J De Aizpurua; Y M Wilson; L C Harrison
Journal:  Proc Natl Acad Sci U S A       Date:  1992-10-15       Impact factor: 11.205

10.  Isolation by anion-exchange of immunologically and enzymatically active human islet glutamic acid decarboxylase 65 overexpressed in Sf9 insect cells.

Authors:  A J Moody; K R Hejnaes; M O Marshall; F S Larsen; E Boel; I Svendsen; E Mortensen; T Dyrberg
Journal:  Diabetologia       Date:  1995-01       Impact factor: 10.122

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.